Trials & R&D · first seen 41m ago, updated 41m ago

2026 IMS | IASO Bio Presents First-in-Human Phase 1 Data of RD140, a Fully Human BCMA/GPRC5D Dual-Targeted FasT CAR-T

1 outlet CAR-T & cell therapy

— Poster presentation selected for the poster discussion session (Abstract No.: PA-200): in a first-in-human study in 9 heavily pretreated, high-risk patients with relapsed/refractory multiple myeloma or plasma cell leukemia, RD140, a fully…

Summary from PR Newswire - Clinical Trials.

Coverage 1 article · 1 outlet

PR Newswire - Clinical Trials 41m ago
2026 IMS | IASO Bio Presents First-in-Human Phase 1 Data of RD140, a Fully Human BCMA/GPRC5D Dual-Targeted FasT CAR-T